Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging
Lu Huang, Peijun Zhao, Dazhong Tang, Tong Zhu, Rui Han, Chenao Zhan, Weiyong Liu, Hesong Zeng, Qian Tao, Liming Xia, Lu Huang, Peijun Zhao, Dazhong Tang, Tong Zhu, Rui Han, Chenao Zhan, Weiyong Liu, Hesong Zeng, Qian Tao, Liming Xia
Abstract
Objectives: This study evaluated cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19) using cardiac magnetic resonance (CMR).
Background: Myocardial injury caused by COVID-19 was previously reported in hospitalized patients. It is unknown if there is sustained cardiac involvement after patients' recovery from COVID-19.
Methods: Twenty-six patients recovered from COVID-19 who reported cardiac symptoms and underwent CMR examinations were retrospectively included. CMR protocols consisted of conventional sequences (cine, T2-weighted imaging, and late gadolinium enhancement [LGE]) and quantitative mapping sequences (T1, T2, and extracellular volume [ECV] mapping). Edema ratio and LGE were assessed in post-COVID-19 patients. Cardiac function, native T1/T2, and ECV were quantitatively evaluated and compared with controls.
Results: Fifteen patients (58%) had abnormal CMR findings on conventional CMR sequences: myocardial edema was found in 14 (54%) patients and LGE was found in 8 (31%) patients. Decreased right ventricle functional parameters including ejection fraction, cardiac index, and stroke volume/body surface area were found in patients with positive conventional CMR findings. Using quantitative mapping, global native T1, T2, and ECV were all found to be significantly elevated in patients with positive conventional CMR findings, compared with patients without positive findings and controls (median [interquartile range]: native T1 1,271 ms [1,243 to 1,298 ms] vs. 1,237 ms [1,216 to 1,262 ms] vs. 1,224 ms [1,217 to 1,245 ms]; mean ± SD: T2 42.7 ± 3.1 ms vs. 38.1 ms ± 2.4 vs. 39.1 ms ± 3.1; median [interquartile range]: 28.2% [24.8% to 36.2%] vs. 24.8% [23.1% to 25.4%] vs. 23.7% [22.2% to 25.2%]; p = 0.002; p < 0.001, and p = 0.002, respectively).
Conclusions: Cardiac involvement was found in a proportion of patients recovered from COVID-19. CMR manifestation included myocardial edema, fibrosis, and impaired right ventricle function. Attention should be paid to the possible myocardial involvement in patients recovered from COVID-19 with cardiac symptoms.
Keywords: ACE2, angiotensin-converting enzyme 2; AHA, American Heart Association; BSA, body surface area; CI, cardiac index; CMR, cardiac magnetic resonance; CO, cardiac output; COVID-19, coronavirus disease-2019; ECV, extracellular volume; EDV, end-diastolic volume; EF, ejection fraction; ER, edema ratio; ESV, end-systolic volume; FA, flip angle; FOV, field of view; IQR, interquartile range; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction; PSIR, phase-sensitive inversion-recovery; RT-PCR, reverse transcription and polymerase chain reaction; RV, right ventricle; RVEF, right ventricular ejection fraction; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; SI, signal intensity; SSFP, steady state free precession; STIR, short tau inversion recovery; SV, stroke volume; T2WI, T2-weighted imaging; TE, echo time; TR, repetition time; cardiac involvement; cardiac magnetic resonance imaging; coronavirus disease-2019; hs-cTnI, high-sensitive cardiac troponin I.
Conflict of interest statement
This work was supported in part by the National Natural Science Foundation of China (81471637 and 81873889), the National Mega Project on Major Infectious Disease Prevention (2017ZX10103005-007), and the National Key Research and Development Program of China (2018YFE0204500). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2020 by the American College of Cardiology Foundation. Published by Elsevier.
Figures
References
- World Health Organization WHO Director-General’s opening remarks at the media briefing on COVID-19 - 30 March 2020. World Health Organization. Available at:
- Shi H., Han X., Jiang N. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;3099:1–10.
- Patel V.B., Basu R., Oudit G.Y. ACE2/Ang 1-7 axis: a critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte. 2016;5:306–311.
- Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;6736:1–10.
- Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1601–1609.
- Knockaert D.C. Cardiac involvement in systemic inflammatory diseases. Eur Heart J. 2007;28:1797–1804.
- Friedrich M.G., Sechtem U., Schulz-Menger J. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53:1475–1487.
- Ferreira V.M., Schulz-Menger J., Holmvang G. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158–3176.
- Kammerlander A.A., Marzluf B.A., Zotter-Tufaro C. T1 mapping by CMR imaging: from histological validation to clinical implication. J Am Coll Cardiol Img. 2016;9:14–23.
- Amano Y., Aita K., Yamada F., Kitamura M., Kumita S. Distribution and clinical significance of high signal intensity of the myocardium on T2-weighted images in 2 phenotypes of hypertrophic cardiomyopathy. J Comput Assist Tomogr. 2015;39:951–955.
- Ho C.Y., Day S.M., Colan S.D. The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers. JAMA Cardiol. 2017;2:419.
- Tao A., Zhenlu Y., Hongyan H. Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 Cases. Radiology. 2020;296:E32–E40.
- National Health Commission of the People’s Republic of China Diagnosis and Treatment Protocol of Novel Coronavirus (trial version 7th). National Health Commission of the People’s Republic of China Website. Available at:
- Luetkens J.A., Doerner J., Thomas D.K. Acute myocarditis: multiparametric cardiac MR imaging. Radiology. 2014;273:383–392.
- Chaikriangkrai K., Abbasi M.A., Sarnari R. Prognostic value of myocardial extracellular volume fraction and T2-mapping in heart transplant patients. J Am Coll Cardiol Img. 2020;13:1521–1530.
- Bohnen S., Radunski U.K., Lund G.K. Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ Cardiovasc Imaging. 2015;8:e003073.
- Li H., Zhu H., Yang Z., Tang D., Huang L., Xia L. Tissue characterization by mapping and strain cardiac MRI to evaluate myocardial inflammation in fulminant myocarditis. J Magn Reson Imaging. 2020;52:930–938.
- Dolan R.S., Rahsepar A.A., Blaisdell J. Multiparametric cardiac magnetic resonance can detect acute cardiac allograft rejection after heart transplantation. J Am Coll Cardiol Img. 2019;12:1632–1641.
- Hinojar R., Varma N., Child N. T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imaging. 2015;8
- Gottbrecht M., Kramer C.M., Salerno M. Native T1 and extracellular volume measurements by cardiac MRI in healthy adults: a meta-analysis. Radiology. 2019;290:317–326.
- Xu J., Zhuang B., Sirajuddin A. MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology. 2020;294:275–286.
- Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831–834.
- Xu Z., Shi L., Wang Y. Case report pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. 2020;8:420–422.
- Zheng Y., Ma Y., Zhang J., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–260.
- Oudit G.Y., Kassiri Z., Jiang C. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618–625.
- Repessé X., Charron C., Vieillard-Baron A. Right ventricular failure in acute lung injury and acute respiratory distress syndrome. Minerva Anestesiol. 2012;78:941–948.
- Osman D., Monnet X., Castelain V. Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome. Intensive Care Med. 2009;35:69–76.
- Huang L., Ran L., Zhao P. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes. Br J Radiol. 2019;92:20190634.
- Florian A., Ludwig A., Rö Sch S., Yildiz H., Sechtem U., Yilmaz A. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Img. 2014;15:1004–1012.
Source: PubMed